Bezeq, Teva, El Al, Nitsba, Protalix: Israel Equity Preview
The following stocks may rise or fall in Israeli markets. Stock symbols are in parentheses after company names and prices are from the last close unless otherwise stated.
The TA-25 Index gained 1.4 percent to 1,267.54 in Tel Aviv on March 17. Israeli markets were closed yesterday for a holiday.
Bezeq Israeli Telecommunication Corp. (BEZQ IT): The country’s biggest communications company said an Israeli court will discuss a planned 3 billion-shekel ($848.7 million) dividend on March 31. Bezeq rose 0.6 percent to 9.95 shekels.
Blue Square Real Estate Ltd. (BLSR) : The property company said fourth-quarter net income increased to 88 million shekels from 81 million shekels a year earlier. Blue Square gained 0.2 percent to 95.13 shekels.
Danya Cebus Ltd. (DNYA) : The construction unit of Africa Israel Investments Ltd. reported 2010 net income that soared to 91.3 million shekels from 1.9 million shekels in 2009. Danya rose 2.9 percent to 16.61 shekels.
El Al Israel Airlines (ELAL) Ltd: The Civil Aviation Authority cancelled yesterday the operating license of Sun D’or, a unit of the country’s national carrier. El Al dropped 2.5 percent to 1.345 shekels.
First International Bank of Israel Ltd. (FTIN) : Israel’s fifth-largest lender was raised to “buy” from “neutral” at IBI-Israel Brokerage & Investments Ltd. The bank advanced 3.2 percent to 51.22 shekels.
Hot Telecommunication System Ltd. (HOT) : The cable- television company said it signed a refinancing agreement with banks that covers 3.4 billion shekels in loans. Hot rose 1.1 percent to 60.61 shekels.
Ormat Industries (ORMT) Ltd: The builder and operator of geothermal plants reported a fourth-quarter loss of $44.3 million after a profit of $11.2 million a year earlier. The company set an $11 million dividend, payable April 12. Ormat gained 0.2 percent to 25.74 shekels.
Nitsba Holdings 1995 Ltd. (NTBA) : The developer of commercial real estate said 2010 net income increased to 384 million shekels from 265.5 million shekels in 2009. Nitsba jumped 6.8 percent to 35.60 shekels.
Protalix BioTherapeutics Inc. (PLX) : The biotechnology company priced an offering of 4 million shares at $5.50 each. Protalix fell 2.3 percent to 22.15 shekels.
Teva Pharmaceutical Industries Ltd. (TEVA) The Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion for NOMAC-E2, a contraceptive tablet.
Separately, the U.S. government and Johnson & Jonson each filed patent-infringement lawsuits to block the company from selling a generic version of the HIV medicine Prezista. Teva gained 0.5 percent to 171.80 shekels.